Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Importance of the Baby-Friendly Hospital Initiative—Reply

The Importance of the Baby-Friendly Hospital Initiative—Reply Letters Published Online: January 23, 2017. doi:10.1001/jamapediatrics.2016.4689 S aureus–associated sepsis are urgently required. However, the evidence base to inform such protocols is sorely lacking. Im- Conflict of Interest Disclosures: None reported. portant questions about the epidemiology and clinical treat- 1. McMullan BJ, Bowen A, Blyth CC, et al. Epidemiology and mortality of Staphylococcus aureus bacteremia in Australian and New Zealand children. ment of staphylococcal bacteremia and sepsis remain, includ- JAMA Pediatr. 2016;170(10):979-986. ing optimal choice and duration of antibiotic therapy, benefit 2. Schlapbach LJ, Straney L, Alexander J, et al; ANZICS Paediatric Study Group. from combination therapy or antitoxin therapy, timing of in- Mortality related to invasive infections, sepsis, and septic shock in critically ill travenous to oral stepdown, and the role of further investiga- children in Australia and New Zealand, 2002-13: a multicentre retrospective tions such as echocardiography in children. cohort study. Lancet Infect Dis. 2015;15(1):46-54. In August 2016, we surveyed Australasian pediatric infec- 3. Saville BR, Berry SM. Efficiencies of platform clinical trials: a vision of the future. Clin Trials. 2016;13(3):358-366. tious diseases physicians on the treatment of S aureus infec- tions in children to understand clinical decision making in simple and complicated S aureus infection scenarios. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Pediatrics American Medical Association

The Importance of the Baby-Friendly Hospital Initiative—Reply

JAMA Pediatrics , Volume 171 (3) – Mar 30, 2017

Loading next page...
 
/lp/american-medical-association/the-importance-of-the-baby-friendly-hospital-initiative-reply-0MzhrfNJ50
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6203
eISSN
2168-6211
DOI
10.1001/jamapediatrics.2016.4795
pmid
28135364
Publisher site
See Article on Publisher Site

Abstract

Letters Published Online: January 23, 2017. doi:10.1001/jamapediatrics.2016.4689 S aureus–associated sepsis are urgently required. However, the evidence base to inform such protocols is sorely lacking. Im- Conflict of Interest Disclosures: None reported. portant questions about the epidemiology and clinical treat- 1. McMullan BJ, Bowen A, Blyth CC, et al. Epidemiology and mortality of Staphylococcus aureus bacteremia in Australian and New Zealand children. ment of staphylococcal bacteremia and sepsis remain, includ- JAMA Pediatr. 2016;170(10):979-986. ing optimal choice and duration of antibiotic therapy, benefit 2. Schlapbach LJ, Straney L, Alexander J, et al; ANZICS Paediatric Study Group. from combination therapy or antitoxin therapy, timing of in- Mortality related to invasive infections, sepsis, and septic shock in critically ill travenous to oral stepdown, and the role of further investiga- children in Australia and New Zealand, 2002-13: a multicentre retrospective tions such as echocardiography in children. cohort study. Lancet Infect Dis. 2015;15(1):46-54. In August 2016, we surveyed Australasian pediatric infec- 3. Saville BR, Berry SM. Efficiencies of platform clinical trials: a vision of the future. Clin Trials. 2016;13(3):358-366. tious diseases physicians on the treatment of S aureus infec- tions in children to understand clinical decision making in simple and complicated S aureus infection scenarios.

Journal

JAMA PediatricsAmerican Medical Association

Published: Mar 30, 2017

References